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Alzheimer’s disease  
― Relationship between the Alzheimer’s disease and human microbiome ―
Yusuke Fujiia,b) and Hidetoshi Moritaa)
(Course of Applied Animal Science)
　Alzheimer’s disease (AD) is a progressive, neurodegenerative disease characterized by memory and 
language disorder. The accumulation of senile plaques called β-amyloid and neurofibrillary tangles 
involving protein tau in the brains of AD patients have been considered as two hallmarks of AD. In AD, 
it is reported that accumulation of β-amyloid may be observed 25 years before onset, supporting early 
diagnosis and treatment by brain image analysis, because several techniques have recently been 
developed to detect β-amyloid and tau protein in brains of persons diagnosed with AD. AD patients are 
usually suffering from other diseases such as diabetes or periodontal disease, and there is accumulating 
data to show that these diseases associate with the human microbiome, such as gut and oral microbiota. 
In this report, the relation ship between AD and the human microbiome is reviewed.
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し，以下の 3 つのステージに分類した．ステージ 1 ：無
症状でありながら脳内アミロイドβの蓄積がみられる状
態，ステージ 2 ：神経変性が始まっている状態，ステー
ジ 3 ：ステージ 2 に軽度の認知機能障害がみられる状態




能低下を示す状態になれば“Dementia due to AD”と定






































ラクトン」であった．例えば，DHA と EPA を強化した
魚肉ソーセージを，57歳以上の健常者に 1 年間摂取した





















































者104名をプラセボ群（n = 30）と20 IU のインスリン投





（n = 20）20 IU のインスリンデテミル投与群（n = 21）



















る．また，Liu ら22）は，口内細菌の Porphyomonas gingi︲
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Fig. 2 　Reduction of amyloid β in GF-APPPS1 transgenic mice28)















































































C：Human bacteria ＋ anti-IL-17ab
Fig. 3 　Human commensal bacteria inducing gut TH17 cells promote abnormal behavioral phenotypes in maternal immune activation 
offspring.31） 
a：Ultra Sonic Vocalization（USV）test. 
b：Marble burying test. 
c：Time spent at the center in open field test. 
d：Social interaction test. 
e：Maternal plasma concentrations of IL-17a.
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